BiVictriX Therapeutics ^Companies

BiVictriX Therapeutics is a biotech company that specializes in the development of cancer therapies. They leverage their frontline clinical experience to create differentiated therapeutics that are highly selective for cancer cells. Their innovative Bi-Cygni® approach effectively unmasks cancer cells, making them visible for targeted treatment. By combining this technology with ADC therapeutic design, they are developing a pipeline of next-generation Bi-Cygni® ADCs with superior cancer selectivity. Their goal is to revolutionize the treatment of patients suffering from aggressive cancers by providing precise and effective therapies.